Encompass Health (NYSE: EHC) director acquires 259 shares in awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Encompass Health Corp director Edward M. Christie III acquired 248 shares of Encompass Health common stock on July 16, 2026 at a weighted average price of $112.43 per share, plus 11 additional shares on July 15, 2026 from dividend-related awards and director fee deferrals, for a total of 259 shares and direct holdings of 9,345 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Christie Edward M III
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Encompass Health Common Stock | 248 | $112.43 | $28K |
| Grant/Award | Encompass Health Common Stock | 11 | $0.00 | -- |
Holdings After Transaction:
Encompass Health Common Stock — 9,345 shares (Direct)
Footnotes (1)
- Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment. The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2025 to defer fixed percentages of their director fees for 2026. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the director's fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.19 per share paid on July 15, 2026. This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.40 to $112.43, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Key Figures
Shares acquired 16 July 2026: 248 shares
Shares acquired 15 July 2026: 11 shares
Holding after transactions: 9,345 shares
+3 more
6 metrics
Shares acquired 16 July 2026
248 shares
Non-derivative acquisition at weighted average $112.43 per share on July 16, 2026
Shares acquired 15 July 2026
11 shares
Non-derivative acquisition associated with dividend-related award on July 15, 2026
Holding after transactions
9,345 shares
Total Encompass Health common stock held directly by Edward M. Christie III after reported acquisitions
Common stock dividend
$0.19 per share
Dividend paid on Encompass Health common stock on July 15, 2026 used to calculate RSU credits
Closing price on dividend date
$109.88
Closing price on July 15, 2026 used in restricted stock unit credit calculation
Purchase price range
$112.40–$112.43
Range of market purchase prices for shares acquired via the deferred fee plan
Key Terms
restricted stock units, Directors Deferred Stock Investment Plan, non-qualified deferral plan, weighted average price
4 terms
restricted stock units financial
"additional restricted stock units are credited to each non-employee director's account"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Directors Deferred Stock Investment Plan financial
"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan"
non-qualified deferral plan financial
"is a non-qualified deferral plan adopted and approved by the Board of Directors"
weighted average price financial
"This per share price is a weighted average price. These shares were purchased"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What is the Directors Deferred Stock Investment Plan at Encompass Health (EHC)?
The Directors Deferred Stock Investment Plan is a non-qualified deferral plan, effective November 1, 2007, allowing non-employee directors to elect during 2025 to defer portions of 2026 fees. Deferred fees are used quarterly to buy Encompass Health stock, with dividends reinvested in additional shares.
How did Encompass Health (EHC) dividends affect Christie's recent equity awards?
On July 15, 2026 Encompass Health paid a $0.19 per share dividend, with a closing price of $109.88. These figures were used to credit additional restricted stock units and to reinvest dividends within the deferred stock plan, contributing to Christie's new equity awards.